Literature DB >> 19533851

The role of endogenous and exogenous ligands for the peroxisome proliferator-activated receptor alpha (PPAR-alpha) in the regulation of inflammation in macrophages.

Concetta Crisafulli1, Salvatore Cuzzocrea.   

Abstract

The aim of the present study was to evaluate the role of endogenous and exogenous peroxisome proliferator-activated receptor alpha (PPAR-alpha), a nuclear receptor, on the regulation of inflammation in macrophages. To address this question, we have stimulated peritoneal macrophages from PPAR-alpha wild-type mice and PPAR-alpha knockout mice (PPAR-alpha) with 10 microg/mL LPS and 100 U/mL IFN-gamma. We report here that the absence of a functional PPAR-alpha gene in PPAR-alpha knockout mice resulted in a significant augmentation of various inflammatory parameters in peritoneal macrophages. In particular, we have clearly demonstrated that PPAR-alpha gene deletion increases (1) the mitogen-activated protein kinase phosphorylation (extracellular signal-regulated kinase, c-Jun NH2-terminal kinase, and p38), (2) nuclear factor-kappaB activation, (3) IkappaB-alpha degradation, (4) iNOS expression and NO formation, and (5) cyclooxygenase 2 expression and prostaglandin E2 formation caused by LPS/IFN-gamma stimulation. On the contrary, the incubation of peritoneal macrophages from PPAR-alpha wild type with clofibrate (2 mM) at 2 h before the LPS and IFN-gamma stimulation significantly reduced the expression and the release of the proinflammatory mediators. To elucidate whether the protective effects of clofibrate is related to activation of the PPAR-alpha receptor, we also investigated the effect of clofibrate treatment on PPAR-alpha-deficient mice. The absence of the PPAR-alpha receptor significantly abolished the protective effect of the PPAR-alpha agonist against LPS/IFN-gamma-induced macrophage inflammation. In conclusion, our study demonstrates that the endogenous and exogenous PPAR-alpha ligands reduce the degree of macrophage inflammation caused by LPS/IFN-gamma stimulation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19533851     DOI: 10.1097/shk.0b013e31818bbad6

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  25 in total

1.  Modification in oxidative stress, inflammation, and lipoprotein assembly in response to hepatocyte nuclear factor 4alpha knockdown in intestinal epithelial cells.

Authors:  Valérie Marcil; Ernest Seidman; Daniel Sinnett; François Boudreau; Fernand-Pierre Gendron; Jean-François Beaulieu; Daniel Ménard; Louis-Philippe Precourt; Devendra Amre; Emile Levy
Journal:  J Biol Chem       Date:  2010-09-24       Impact factor: 5.157

2.  Peroxisome proliferator-activated receptor alpha expression changes in human pregnant myometrium.

Authors:  Kun Dong; Ming-Xiang Zhang; Yuan Liu; Xue-Lian Su; Bin Chen; Xiang-Li Zhang
Journal:  Reprod Sci       Date:  2012-11-09       Impact factor: 3.060

3.  Lack of PPARα exacerbates lipopolysaccharide-induced liver toxicity through STAT1 inflammatory signaling and increased oxidative/nitrosative stress.

Authors:  Seong Ho Yoo; Ogyi Park; Lauren E Henderson; Mohamed A Abdelmegeed; Kwan-Hoon Moon; Byoung-Joon Song
Journal:  Toxicol Lett       Date:  2011-01-22       Impact factor: 4.372

Review 4.  PPARs and pain.

Authors:  Bright N Okine; Jessica C Gaspar; David P Finn
Journal:  Br J Pharmacol       Date:  2018-06-03       Impact factor: 8.739

5.  Regulation of URG4/URGCP and PPARα gene expressions after retinoic acid treatment in neuroblastoma cells.

Authors:  Cigir Biray Avci; Yavuz Dodurga; Gulsah Gundogdu; Hasan Onur Caglar; Vural Kucukatay; Cumhur Gunduz; N Lale Satiroglu-Tufan
Journal:  Tumour Biol       Date:  2013-07-03

Review 6.  Role of peroxisome proliferator-activated receptors in non-alcoholic fatty liver disease inflammation.

Authors:  Amanda Karolina Soares Silva; Christina Alves Peixoto
Journal:  Cell Mol Life Sci       Date:  2018-05-22       Impact factor: 9.261

7.  PPARα mediates the anti-inflammatory effect of simvastatin in an experimental model of zymosan-induced multiple organ failure.

Authors:  Barbara Rinaldi; Maria Donniacuo; Emanuela Esposito; Annalisa Capuano; Loredana Sodano; Emanuela Mazzon; Donatella Di Palma; Irene Paterniti; Salvatore Cuzzocrea; Francesco Rossi
Journal:  Br J Pharmacol       Date:  2011-06       Impact factor: 8.739

8.  Dynamic, M2-like remodeling phenotypes of CD11c+ adipose tissue macrophages during high-fat diet--induced obesity in mice.

Authors:  Merav E Shaul; Grace Bennett; Katherine J Strissel; Andrew S Greenberg; Martin S Obin
Journal:  Diabetes       Date:  2010-02-25       Impact factor: 9.461

Review 9.  PPARalpha: energy combustion, hypolipidemia, inflammation and cancer.

Authors:  Sean R Pyper; Navin Viswakarma; Songtao Yu; Janardan K Reddy
Journal:  Nucl Recept Signal       Date:  2010-04-16

10.  Coactivators in PPAR-Regulated Gene Expression.

Authors:  Navin Viswakarma; Yuzhi Jia; Liang Bai; Aurore Vluggens; Jayme Borensztajn; Jianming Xu; Janardan K Reddy
Journal:  PPAR Res       Date:  2010-08-05       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.